Patent · US Active

Methods for amyloid removal using anti-amyloid antibodies

US8105594B2 · kind B2 · utility

9Cited by
75References
14Claims
0Family size

Inventors

Key dates

Filing dateJan 25, 2010
Grant dateJan 31, 2012
Priority date—
Expiry dateJan 25, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and related immunoglobulin peptides and fragments thereof are disclosed that enhance the cell-mediated immune response of a patient to deposits of amyloid fibrils. These methods exploit the opsonizing effect of antibodies directed toward amyloid material or its component parts.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.